Synthesis and antiinflammatory screening of some quinazoline and quinazolyl-4-oxoquinazoline derivatives. 2002

Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
Pharmaceutical Organic Chemistry, College of Pharmacy, Mansoura University, Mansoura 35516, Egypt. maggineinah@yahoo.com

Synthesis of some new derivatives of 2-aryl-4-oxo-1-(4-quinazolyl)quinazolines is described. Methyl N-(4-quinazolyl)anthranilate was allowed to react with phenyl iso(thio)cyanate to give 3-phenyl-1-(4-quinazolyl)-1, 2, 3, 4-tetrahydro-2, 4-dioxo- and 4-oxo-2-thioxoquinazolines (3a and 3b respectively) Alternatively, anthranilic acid amide derivatives were subjected to cyclization with aromatic aldehydes to give 2-aryl-4-oxo-1-(4-quinazolyl)-1, 2, 3, 4-tetrahydroquinazolines 5. On the other hand, 2-chloro-4-(4-substituted 1-piperazinyl)quinazoline derivatives were subjected to the same type of reactions at the 2-position to afford the corresponding quinazoline derivatives 8 and 10 respectively. Furthermore, the acid amide 4b cyclized with acid chlorides to give the corresponding 2-aryl-1-(2-chloro-4-quinazolyl)-4-oxo-1, 4-dihydroquinazolines 11 from which the triazoloquinazoline derivatives 13 and 15 were synthesized through the intermediate hydrazine derivatives 12. Most of the newly synthesized compounds were tested for their antiinflammatory activities. However, some of the novel compounds were found to exhibit good antiinflammatory potencies.

UI MeSH Term Description Entries
D008297 Male Males
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
January 1964, Acta poloniae pharmaceutica,
Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
October 1983, Journal of medicinal chemistry,
Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
January 1974, Farmatsevtychnyi zhurnal,
Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
November 2022, European journal of medicinal chemistry,
Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
January 2012, Bioorganic & medicinal chemistry letters,
Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
October 1983, Journal of medicinal chemistry,
Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
March 1997, Die Pharmazie,
Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
February 1996, Farmaco (Societa chimica italiana : 1989),
Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
July 1995, Die Pharmazie,
Magdy M Gineinah, and Magda A El-Sherbeny, and Magda N Nasr, and Azza R Maarouf
November 2000, Archiv der Pharmazie,
Copied contents to your clipboard!